At Singapore’s gleaming Biopolis complex, researchers get all the money and lab support they need. What they don’t get is time.
Pharmaceutical companies are finding that reducing waste in drug manufacturing can also save them millions of dollars.
Jeffrey Segal and his firm, Medical Justice, are using waivers to combat what they see as unfair online reviews of doctors.
A long campaign halved the percentage of U.S. smokers. Could a similar effort succeed against the nation’s obesity epidemic?
To save money and increase quality of care for Medicare patients, the government is considering denying payment to hospitals for certain procedures.
Paul A. Offit, an infectious disease specialist, discusses the costs of not vaccinating children for fear of autism.
Michael G. Fitzsimons, head of the drug-testing program at the Massachusetts General Hospital’s Department of Anesthesia and Critical Care, discusses preventing fallout from addicted physicians.
Art and message merged in twentieth-century posters, raising the alarm about contagions from TB to AIDS.
Ordinarily resistant to economic ills, health care this time is suffering too. Poor and uninsured patients are most at risk.
They work without employees, fancy offices or big incomes. But back-to-basics doctors cite one elusive perk: satisfaction.
No Articles Found.
Stay on the frontiers of medicine